NCT07502794 Long-term Assessment of Patients Treated in the ICU for Sepsis
| NCT ID | NCT07502794 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital Israelita Albert Einstein |
| Condition | Sepsis |
| Study Type | OBSERVATIONAL |
| Enrollment | 760 participants |
| Start Date | 2026-06-18 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 760 participants in total. It began in 2026-06-18 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a prospective, observational cohort clinical registry designed to describe clinical and epidemiological characteristics and outcomes of adult patients hospitalized with sepsis. Participants will be followed during hospitalization and after hospital discharge to evaluate short- and long-term outcomes.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of sepsis or septic shock during ICU hospitalization, according to the Sepsis-3 definition. * Age ≥18 years. * Written informed consent obtained from the participant or a legally authorized representative. Exclusion Criteria: * Limited prognosis with a life expectancy of less than 3 months due to conditions not related to sepsis. * Refusal to participate in the study
Contact & Investigator
Henrique A R Fonseca
STUDY CHAIR
ARO-Einstein - Hospital Israelita Albert Einstein
Frequently Asked Questions
Who can join the NCT07502794 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sepsis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07502794 currently recruiting?
Yes, NCT07502794 is actively recruiting participants. Contact the research team at luciano.azevedo@einsten.br for enrollment information.
Where is the NCT07502794 trial being conducted?
This trial is being conducted at Passo Fundo, Brazil.
Who is sponsoring the NCT07502794 clinical trial?
NCT07502794 is sponsored by Hospital Israelita Albert Einstein. The principal investigator is Henrique A R Fonseca at ARO-Einstein - Hospital Israelita Albert Einstein. The trial plans to enroll 760 participants.